GLP-1RA prescription trends, real-world effectiveness, and predictors for access and rationing were highlighted at ...

It’s hard to watch the news or scroll through social media without encountering stories about weight loss drugs like ...

Hims & Hers Health launched a GLP-1 Supply Tracker to spotlight challenges in accessing obesity medications, addressing ...

Our upcoming milestones offer the potential to unlock a high-impact and high-value portfolio ... First, as a monotherapy, ...

Doctors from around the world joined forces to study a medication called semaglutide for type 2 diabetes. The research took ...

A recent study has found that higher doses of semaglutide, a common medication for type 2 diabetes, could offer better ...

SAN ANTONIO -- Research presented at the ObesityWeek annual meeting included studies on rationing of prescription medications ...

Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

Corbus Pharmaceuticals still shows promise, with CRB-701 and CRB-601 advancing in clinical trials. Read why CRBP stock is ...